Non-alcoholic Steatohepatitis Treatment Market Worth $15.95 Billion By 2030

Non-Alcoholic Steatohepatitis Treatment Market Growth & Trends

Non-Alcoholic Steatohepatitis Treatment Market Report Highlights

  • Vitamin E and Pioglitazone (Off-label) acted as the lone contributor with a 100% share of the market in 2021. This can be attributed to the unavailability of approved drugs in the market
  • The retail and specialty pharmacies segment held a share of 63.8% in 2021. Retail and specialty pharmacies are more compatible with chronic diseases such as NASH, where the patients are more commonly associated with homecare settings
  • North America dominated the overall NASH treatment space in terms of revenue. This can be attributed to increased disease awareness, better healthcare facilities, and comparatively higher treatment rate than in other regions

--

--

Company provides syndicated research reports, customized research reports, and consulting services

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Rajesh Varma

Hello guys I am Market Research Analyst @ Grand View Research, preparing and publish research report on Technology, Next Generation Technologies